Kinetic of T cell reactivity and antibody responses to SARS-CoV-2 after different rounds of vaccination in persons with multiple sclerosis treated with ocrelizumab / Tarkowski, M; Mandelli, A; Gabrieli, A; Finardi, A; Zanetta, C; Pedotti, R; Raposo, C; Rocca, Ma; Moiola, L; Filippi, M; Riva, A; Furlan, R. - In: MULTIPLE SCLEROSIS. - ISSN 1352-4585. - 29:3S(2023), pp. 1104-1104.

Kinetic of T cell reactivity and antibody responses to SARS-CoV-2 after different rounds of vaccination in persons with multiple sclerosis treated with ocrelizumab

Rocca, MA;Filippi, M;Furlan, R
Ultimo
2023-01-01

2023
Inglese
MSMilan2023
SAGE PUBLICATIONS LTD
1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
29
3S
1104
1104
1
Esperti anonimi
Goal 3: Good health and well-being
No
12
info:eu-repo/semantics/conferenceObject
Kinetic of T cell reactivity and antibody responses to SARS-CoV-2 after different rounds of vaccination in persons with multiple sclerosis treated with ocrelizumab / Tarkowski, M; Mandelli, A; Gabrieli, A; Finardi, A; Zanetta, C; Pedotti, R; Raposo, C; Rocca, Ma; Moiola, L; Filippi, M; Riva, A; Furlan, R. - In: MULTIPLE SCLEROSIS. - ISSN 1352-4585. - 29:3S(2023), pp. 1104-1104.
none
274
4 Contributo in Atti di Convegno (Proceeding)::4.2 Abstract in Atti di convegno
Tarkowski, M; Mandelli, A; Gabrieli, A; Finardi, A; Zanetta, C; Pedotti, R; Raposo, C; Rocca, Ma; Moiola, L; Filippi, M; Riva, A; Furlan, R
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/179620
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact